Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Strong Through Knowledge

DKFZ’s Cancer Information Service (KID) shows that evidence-based cancer information promotes patients’ self-competence

No. 16 | 14/03/2013 | by aj/KID

© dkfz.de

The Cancer Information Service (KID) of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), as a National Reference Center for Cancer Information, advances public health competence in Germany. “Making decisions despite uncertainties” is the theme of the 14th Annual Conference of the German Network for Evidence Based Medicine (Deutsches Netzwerk Evidenzbasierte Medizin, DNEbM) on March 15 and 15 in Berlin, where the Cancer Information Service will report first results of a survey among users of the telephone cancer information service. The service reaches out to patients, family members and health professionals. As a DNEbM sustaining member, the Cancer Information Service helps to disseminate and advance concepts and methods of evidence-based medicine (EBM) in healthcare.

“Health professionals, patients and the interested public benefit from the excellent quality of our cancer information, which is unique in Germany. The service bundles scientifically founded information and communicates it in a comprehensible way, tailored to the individual needs of those seeking advice. Our special value is that all information provided is evidence-based and free of any trends or individual expert opinions. And it has no commercial aims whatsoever,” says Dr. Susanne Weg-Remers, director of the Cancer Information Service.

An important prerequisite for well-founded decisions is to have scientifically founded information. The Cancer Information Service offers such information via telephone, e-mail and the Internet. With its neutral and evidence-based quality of information, the Cancer Information Service supports the goals of the German Network for Evidence Based Medicine: providing public healthcare based on best scientific knowledge. The Cancer Information Service is thus making an important contribution to public health policy. Weg-Remers continued that although trends may give an impetus in decision-making, when it comes to cancer and its treatment they fail to meet the standards defined by the DNEbM in its “Good Practice in Health Information” (Gute Praxis Gesundheitsinformation, GPGI) guidelines, which aim to assure quality of health information and to protect the public from unreliable, biased and misleading health information. “This also includes naming uncertainties in the absence of evidence-based knowledge,” Weg-Remers adds.

Information provided by the Cancer Information Service promotes self-competence

A non-representative survey conducted among callers of the Cancer Information Service shows that interest in obtaining information is very strong (87 percent of callers wish to learn as much as possible about their disease). Callers are also very interested in being involved in medical decisions (84 percent). About 90 percent of those questioned rated the information provided as very helpful. A total of 3,658 callers including 1,997 patients took part in the survey answering questions about their overall satisfaction with the conversation and whether it helped to improve their understanding of treatment options, orientation, validation of information and to make them feel more certain.

Conclusion: As expected, evidence-based, individually relevant and comprehensible information in accordance with the GPGI guidelines have predominantly positive effects on people’s ability to cope with the disease and on their self-competence.

First survey results will be presented at the conference.

Please find more information at www.ebm-netzwerk.de.

The Cancer Information Service (KID) answers your questions:
Phone (toll-free within Germany): 0800 - 420 30 40, free of charge daily from 8 a.m. to 8 p.m. From abroad the telephone number is +49 (0)6221 999 8000 (chargeable).
E-mail: krebsinformationsdienst@dkfz.de
www.krebsinformationsdienst.de

Cancer information has one number: 0800 - 420 30 40

The Cancer Information Service (KID) has been the contact point for all questions about cancer since 1986. On its website, the service provides up-to-date knowledge, useful tips, addresses, links and references to specialist sources. It answers questions of advice-seekers via telephone, e-mail and face-to-face counseling offered in Heidelberg and Dresden. On the social network Facebook, it provides up-to-date news and invites users to share their views in discussions. The Cancer Information Service is a publicly funded service provided free of charge by the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). It therefore provides independent information that is free of any conflicts of interest and of any advertising.

Contact persons for journalists:

German Cancer Research Center (DKFZ)
Dr. Stefanie Seltmann
Head of Press and Public Relations
German Cancer Research Center
Im Neuenheimer Feld 280
D-69120 Heidelberg
Germany
Phone: +49 6221 42-2854
Fax: +49 6221 42-2968
E-mail: S.Seltmann@dkfz.de
www.dkfz.de

Cancer Information Service (KID) of the German Cancer Research Center Heidelberg
Dr. Antje Jantz
Communication and Marketing
Im Neuenheimer Feld 280
D-69120 Heidelberg
Germany
Phone: +49 6221 42-2125
Fax: +49 6221 42-1806
E-mail: a.jantz@dkfz.de
www.krebsinformationsdienst.de

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS